Literature DB >> 866578

Long-term haematological complications of thorotrast.

S A Johnson, C J Bateman, M E Beard, J M Whitehouse, A H Waters.   

Abstract

Six cases representing the spectrum of haematological complications due to systemic administration of Thorotrast are reposted. Two patients suffered from acute leukaemia, one patient had marrow failure and three patients presented with haematological features of hyposplenism; two of these also had solid tumours. The literature is reviewed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 866578

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  4 in total

1.  Thorotrast administration followed by myelofibrosis.

Authors:  A G Arnold; M H Oelbaum
Journal:  Postgrad Med J       Date:  1980-02       Impact factor: 2.401

2.  Haemangioendothelioma (Kupffer cell angiosarcoma), myelofibrosis, splenic atrophy, and myeloma paraproteinaemia after parenteral thorotrast administration.

Authors:  R C Jennings; S E Priestley
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

3.  Clinicopathological study of hematological disorders after Thorotrast administration in Japan.

Authors:  R Kamiyama; Y Ishikawa; S Hatakeyama; T Mori; H Sugiyama
Journal:  Blut       Date:  1988-04

4.  Angiosarcoma of the liver: a marker tumour for the late effects of Thorotrast in Great Britain.

Authors:  P J Baxter; A O Langlands; P P Anthony; R N Macsween; P J Scheuer
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.